Zymeworks Inc. (ZYME)
NASDAQ·Healthcare·Biotechnology
$27.14
-1.56%
Mkt Cap $2.03B
Analyst Ratings
Buy
11
Hold
0
Sell
0
Price Target (21 analysts)
$40.50
Range $31.00 – $48.00
Implied Upside
+49.3%
Consensus $40.50 vs current $27.14
NASDAQ·Healthcare·Biotechnology
$27.14
-1.56%
Mkt Cap $2.03B
Buy
11
Hold
0
Sell
0
Price Target (21 analysts)
$40.50
Range $31.00 – $48.00
+49.3%
Consensus $40.50 vs current $27.14